Published: 23. September, 2022
Cessatech A/S announces positive topline outcome of its Phase 2 pharmacokinetics trial with CT001…
Cessatech A/S announces positive topline outcome of its Phase 2 pharmacokinetics trial with CT001 in children, which met the primary endpoint of the trial. The trial was designed as a non-randomised, open-label study carried out in 25 children aged 1-17 years who needed premedication for placement of a peripheral venous catheter for general anaesthesia related to a surgical procedure
